Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracy

Circulating microRNAs: next-generation biomarkers for early lung cancer detection / F. Bianchi, F. Nicassio, G. Veronesi, P.P. Di Fiore. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - 6:246(2012), pp. 246.1-246.5. [10.3332/ecancer.2012.246]

Circulating microRNAs: next-generation biomarkers for early lung cancer detection

P.P. Di Fiore
Ultimo
2012

Abstract

Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracy
Settore MED/04 - Patologia Generale
Article (author)
File in questo prodotto:
File Dimensione Formato  
can-6-246.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 341.59 kB
Formato Adobe PDF
341.59 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/178996
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 15
  • ???jsp.display-item.citation.isi??? ND
social impact